Asthma is a common chronic inflammatory disease that makes it harder to move air in and out of the lungs.
Exposure to triggers such as allergens or irritants can lead to asthma attacks. The disease causes narrowing and swelling of the airways leading to symptoms including difficulty breathing, wheezing, coughing and tightness in the chest.
Although there is no cure, symptoms may be prevented by avoiding triggers and through established maintenance therapies including bronchodilators, inhaled corticosteroids, anti-inflammatory agents including biologics, anti-IgE agents and leukotriene inhibitors.
According to WHO estimates, more than 260 million people worldwide were affected by asthma in 2019. In the US alone, the yearly economic burden of asthma was over $80 billion in 2013. The CDC estimated approximately 60% of US adult asthmatics in 2019 had uncontrolled asthma despite regularly taking medication.
Chronic obstructive pulmonary disease (COPD) is a progressive lung condition without a cure. It damages the airways and lungs, leading to debilitating breathlessness.
Cystic fibrosis (CF) is a potentially fatal genetic disease characterized by the build-up of thick, sticky mucus and infection that can damage many of the body’s organs.
Non-Cystic Fibrosis Bronchiectasis (NCFBE) is a chronic lung disease with no FDA-approved treatment. Patients suffer from persistent cough, excess sputum production and frequent respiratory infections.
We welcome inquires from healthcare professionals seeking to learn more.